Harvard Bioscience Inc (HBIO): Shares Outstanding

Annual figures by period end, from SEC filings.

Stock splits: 1-for-10, first reflected in a filing dated 2026-05-12. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

44.72M
As of 2025-12-31
4.55M
As of 2026-06-30
+2.0%
3-year compound annual growth
+2.6%
5-year compound annual growth
+2.8%
10-year compound annual growth
2010-12-31: 28.31M2011-12-31: 28.54M2012-12-31: 29.38M2013-12-31: 31.64M2014-12-31: 32.56M2015-12-31: 33.98M2016-12-31: 34.44M2017-12-31: 35.02M2018-12-31: 37.38M2019-12-31: 38.19M2020-12-31: 39.41M2021-12-31: 41.14M2022-12-31: 42.08M2023-12-31: 43.39M2024-12-31: 44.07M2025-12-31: 44.72M44.72M
2010-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-3144.72M+1.5%2026-03-13, Balance as of period end
2024-12-3144.07M+1.6%2026-03-13, Balance as of period end
2023-12-3143.39M+3.1%2025-03-14, Balance as of period end
2022-12-3142.08M+2.3%2024-03-07, Balance as of period end
2021-12-3141.14M+4.4%2023-03-09, Balance as of period end
2020-12-3139.41M+3.2%2022-03-11, Balance as of period end
2019-12-3138.19M+2.2%2021-03-17, Balance as of period end
2018-12-3137.38M+6.7%2020-03-16, Balance as of period end
2017-12-3135.02M+1.7%2019-03-18, Balance as of period end
2016-12-3134.44M+1.4%2018-03-16, Balance as of period end
2015-12-3133.98M+4.3%2017-03-17, Balance as of period end
2014-12-3132.56M+2.9%2016-04-29, Balance as of period end
2013-12-3131.64M+7.7%2015-03-12, Balance as of period end
2012-12-3129.38M+2.9%2014-03-14, Balance as of period end
2011-12-3128.54M+0.8%2013-03-18, Balance as of period end
2010-12-3128.31Mn/a2012-03-15, Balance as of period end